Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - Concepedia

Concepedia

Publication | Open Access

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

DOI Full Paper Access

1.4K

Citations

27

References

2020

Year

Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jingxin Li, Shi-Po Wu, Busen Wang, Zhao Wang, Lei Wang,

References

	Year	Citations

Page 1